SLU-PP-332 is being promoted as an “exercise mimetic” that may increase fat oxidation, endurance, and energy expenditure. But it is not actually a peptide, it is not FDA-approved, and the most compelling evidence comes from cell and mouse research—not human clinical trials.
In this episode, John Garrett, RN, explains estrogen-related receptors, mitochondrial energy metabolism, the published preclinical findings, the oral-bioavailability problem, potential risks, regulatory status, and the difference between mimicking selected exercise pathways and replacing physical exercise.
This content is for education and discussion only and is not medical advice. SLU-PP-332 is an experimental research compound with no established human therapeutic use.
Learn more: PeptidesExplained.info
Peptide Solutions: Peptide-Solutions.info
Offline Peptides: PeptidesExplained.info/OfflinePeptides
Affiliate disclosure: Peptides Explained is an affiliate partner with OfflinePeptides.com. If you use my link, I may earn a commission at no additional cost to you.
Send 2–3 minute N=1 videos to john@peptidesexplained.info.